hotspot -WSS

hotspot

author：entertainment 2025-09-02 17:49:47 - browse：325

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： My daughter's legacy lives on through her writing, phage therapy

WSS

The stability of $0 premiums in Medicare Advantage

Report captures long Covid’s disabling effects and policy challenges

Cheap, fast test for Zika and dengue could cost just $1

Study points to new risk in gene therapy death of Terry Horgan

Stephen Quake on the Chan Zuckerberg quest to conquer disease

2023 Nobel Prize in Medicine goes to Karikó and Weissman

focus

hotspot

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Some top drug companies are starting to take action on climate

As demand for Covid shots wanes, Moderna seeks its next success

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Medical leaders decry Supreme Court decision on affirmative action

Health care court cases: Humana, Sutter, Novant

As demand for Covid shots wanes, Moderna seeks its next success

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Anesthesiologist group: stop taking Ozempic before surgery

My daughter's legacy lives on through her writing, phage therapy

hotspot

Medicare innovation center doesn’t save money, experts say

The biotech scorecard for Q4: 16 stock

Cheap, fast test for Zika and dengue could cost just $1

STAT Virtual Event: ASCO Recap, Live!

Cigna wins case to block Amy Bricker's move to CVS

My daughter's legacy lives on through her writing, phage therapy

explore

explore

entertainment

explore